Mibioresearch (Labcorp) offers an integrated suite of non‑clinical and central laboratory services that support every phase of drug development, from toxicology and pharmacology studies to clinical trial bioanalysis, biomarker discovery, genomics testing, and companion‑diagnostic development. Leveraging a global network of certified labs, the company provides rapid, regulatory‑ready data, scientific consulting, and post‑approval commercialization support to help biopharma sponsors accelerate timelines and reduce operational risk.
Funding
Funding not disclosed
Founders
Product
Problem
Biopharma companies face complex, multi‑phase drug development that requires extensive toxicology, pharmacology, metabolism, biomarker, genomics, and companion‑diagnostic data, often across many global sites. Coordinating these studies, meeting regulatory expectations, and obtaining timely, high‑quality analytical results can be slow, costly, and prone to data gaps.
Solution
Mibioresearch (Labcorp) provides an integrated suite of non‑clinical and central laboratory services that support every stage of drug development, from early toxicology and pharmacology studies to clinical trial bioanalysis, biomarker discovery, genomics testing, and companion‑diagnostic development. Their global network of certified labs generates the largest volume of clinical trial data worldwide, offering rapid turnaround, regulatory‑ready reporting, and strategic scientific consulting. The company also offers commercialization support, including CDx development, sponsored testing, and data‑driven applications, enabling sponsors to accelerate development timelines, reduce operational risk, and bring therapies to market more efficiently.
Target Audience
Primary customers are pharmaceutical and biotechnology companies developing small‑molecule, biologic, cell, or gene‑therapy programs that require end‑to‑end laboratory and data services across preclinical and clinical phases.
Features
- Comprehensive non‑clinical services (toxicology, pharmacology, metabolism) with scientific advice and regulatory strategy support
- Central lab capabilities covering bioanalysis, biomarkers, genomics, and companion‑diagnostic testing for clinical trials
- Expertise in emerging modalities such as cell and gene therapies and biologics
- Global trial support in over 100 countries with standardized sample logistics and data management
- Integrated consulting on biomarker‑driven trial design, specimen routing, and regulatory compliance
- Post‑approval commercialization services including CDx development, sponsored testing, and proprietary data applications
- Secure, cloud‑based data delivery and reporting compatible with industry standards (e.g., FHIR)